"An article published in the Wall Street Journal today questions when Merck knew their pain drug Vioxx caused patients to experience an increase in the risk of suffering heart problems.
"The article indicated a Merck panel looking at the safety of the arthritis pain drug had information that Vioxx increased the risk of heart problems after four months of patient use.
"The information appears to conflict with a statement Merck made when the drug maker pulled Vioxx off the market in September." [Health Talk]
